Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative viral pathogen of coronavirus disease 2019 (COVID-19), appears to have various clinical presentations and may result in severe respiratory failure. The global SARS-CoV-2-associated viral pneumonia pandemic was first reported...
Main Authors: | Chih-Jen Yang, Yu-Jui Wei, Hsu-Liang Chang, Pi-Yu Chang, Chung-Chen Tsai, Yen-Hsu Chen, Po-Ren Hsueh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S168411822030236X |
Similar Items
-
Remdesivir in renal transplant patients with coronavirus disease 2019: An observational study
by: Muzamil Latief, et al.
Published: (2022-01-01) -
The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review
by: Amirhossein Roshanshad, et al.
Published: (2020-10-01) -
Remdesivir – Current evidence & perspective in management of COVID-19 infection
by: Jyoti Bajpai, et al.
Published: (2021-01-01) -
Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
by: Azza Sarfraz, et al.
Published: (2021-01-01) -
A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient
by: Shmeylan Al Harbi, et al.
Published: (2022-01-01)